The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.
申请公布号
AU2009279473(B2)
申请公布日期
2012.12.13
申请号
AU20090279473
申请日期
2009.08.07
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
ZHOU, JINGYE;XIAO, XIAO-YI;PLAMONDON, LOUIS;HUNT, DIANA KATHARINE;CLARK, ROGER B.;ZAHLER, ROBERT B.
